Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Betty Chang

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|August 13, 2022
Robotic single-port surgery: Preliminary experience in general surgeryFrancesco M Bianco, Nicolas H Dreifuss, Betty Chang, et al.
Frontiers in Immunology|July 25, 2022
Targeting Multiple End Organs in Lupus and Other Systemic Rheumatic Diseases by Inhibiting Bruton's Tyrosine KinaseYong Du, Ling Lei, Huihua Ding, et al.
Nature Genetics|April 4, 2006
Systematic identification of human mitochondrial disease genes through integrative genomicsSarah Calvo, Mohit Jain, Xiaohui Xie, et al.
Clinical Immunology (Orlando, Fla.)|June 1, 2007
Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitorPolly R Pine, Betty Chang, Nathan Schoettler, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 1, 2004
Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in VDR transactivation during keratinocyte differentiationYuko Oda, Carina Sihlbom, Robert J Chalkley, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2003
Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiationYuko Oda, Carina Sihlbom, Robert J Chalkley, et al.
Journal of Medicinal Chemistry|June 27, 2008
Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid estersJun Xu, Derek C Cole, Chao-Pei Betty Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancyLee A Honigberg, Ashley M Smith, Mint Sirisawad, et al.
The Journal of Clinical Investigation|November 4, 2015
Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphomaRebecca L Goldstein, Shao Ning Yang, Tony Taldone, et al.
Arthritis and Rheumatism|April 29, 2008
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupusFrances Rena Bahjat, Polly R Pine, Andrea Reitsma, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|August 13, 2022
Robotic single-port surgery: Preliminary experience in general surgeryFrancesco M Bianco, Nicolas H Dreifuss, Betty Chang, et al.
Frontiers in Immunology|July 25, 2022
Targeting Multiple End Organs in Lupus and Other Systemic Rheumatic Diseases by Inhibiting Bruton's Tyrosine KinaseYong Du, Ling Lei, Huihua Ding, et al.
Nature Genetics|April 4, 2006
Systematic identification of human mitochondrial disease genes through integrative genomicsSarah Calvo, Mohit Jain, Xiaohui Xie, et al.
Clinical Immunology (Orlando, Fla.)|June 1, 2007
Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitorPolly R Pine, Betty Chang, Nathan Schoettler, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 1, 2004
Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in VDR transactivation during keratinocyte differentiationYuko Oda, Carina Sihlbom, Robert J Chalkley, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2003
Two distinct coactivators, DRIP/mediator and SRC/p160, are differentially involved in vitamin D receptor transactivation during keratinocyte differentiationYuko Oda, Carina Sihlbom, Robert J Chalkley, et al.
Journal of Medicinal Chemistry|June 27, 2008
Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid estersJun Xu, Derek C Cole, Chao-Pei Betty Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancyLee A Honigberg, Ashley M Smith, Mint Sirisawad, et al.
The Journal of Clinical Investigation|November 4, 2015
Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphomaRebecca L Goldstein, Shao Ning Yang, Tony Taldone, et al.
Arthritis and Rheumatism|April 29, 2008
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupusFrances Rena Bahjat, Polly R Pine, Andrea Reitsma, et al.
Pageof 8